Darzalex SC
Brand Name: Darzalex SC
Generic Name: Daratumumab
Active
Registration Number
BR-1424
Dosage Form
Solution for Injection (SC)
Issuance Date
October 7, 2022
Expiry Date
October 7, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength1,800 mg/15 mL (120 mg/mL)
PackagingSingle dose. Type I clear glass vial with grey bromobutyl
rubber stopper and aluminum seal with dark grey polypropylene flip-off cap x 15 mL (Box of 1's).
Classification
C
Classification
Prescription Drug (RX)
A
Application
Monitored Release
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
DaratumumabActive
Monograph: Daratumumab